Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Iomed, Inc. · Predicate Candidate Screening
17 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
140 daysmedian FDA review time
605 days90th percentile
17clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K063465 | CHAMPION IONTOPHORETIC DRUG DELIVERY DEVICE | Iomed, Inc. | 2007-02-28 | 104 | 0 |
| K060236 | MW-1000 IONTOPHORETIC DRUG DELIVERY ELECTRODE | Iomed, Inc. | 2006-03-31 | 60 | 0 |
| K033192 | RH-950 | Iomed, Inc. | 2003-12-22 | 81 | 0 |
| K031115 | RH-900 | Iomed, Inc. | 2003-07-10 | 93 | 0 |
| K001522 | TRANSQ3 | Iomed, Inc. | 2000-10-18 | 155 | 0 |
| K001410 | PHORESOR MODEL PM2000 | Iomed, Inc. | 2000-08-01 | 89 | 0 |
| K982668 | PHORESOR II,MODEL PM900 | Iomed, Inc. | 1999-03-02 | 214 | 0 |
| K974855 | PHORESOR II, MODEL PM900 | Iomed, Inc. | 1998-03-27 | 88 | 0 |
| K954126 | TRANSQ ELECTRODE PHORESOR II | Iomed, Inc. | 1996-01-19 | 140 | 0 |
| K932621 | RH-801/GS MODEL TRANSQ(R)1 | Iomed, Inc. | 1994-07-26 | 420 | 0 |
| K934335 | PHORESOR II AUTO, MODEL PM800 MODIFICATION | Iomed, Inc. | 1994-07-26 | 322 | 0 |
| K932620 | RH-806/GS MODEL TRANSQ(R)2 | Iomed, Inc. | 1994-07-26 | 420 | 0 |
| K925806 | RH-801, MODEL TRANSQ | Iomed, Inc. | 1994-07-14 | 605 | 0 |
| K925800 | RH-806, MODEL TRANSQ | Iomed, Inc. | 1994-07-14 | 605 | 0 |
| K914621 | IONTOPHORESIS DEVICE, MODIFICATION | Iomed, Inc. | 1991-12-20 | 100 | 0 |
| K914264 | TRANSQ 2 | Iomed, Inc. | 1991-12-20 | 88 | 0 |
| K896444 | IONTOPHORESIS DEVICE - ELECTRODE RH 800 | Iomed, Inc. | 1990-05-10 | 182 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda